Urol. praxi. 2018;19(2):76-80 | DOI: 10.36290/uro.2018.061
Current treatment options for cancer pain
- Centrum léčby bolesti, Klinika anesteziologie, resuscitace a intenzivní medicíny, LF UK a FN Plzeň
The treatment of cancer pain is an important part of a comprehensive oncological approach. Pharmacotherapy with strongopioids is of crucial importance. The currently available opioid agents, including opioids for the control of breakthrough pain,allow for appropriate individualization of pain management. The use of additional, more recent options of pharmacotherapy,such as cannabinoids, adjuvant analgesics, antidepressants, and local treatment agents, can contribute to improving the qualityof analgesia. In the case of refractory pain, interventional pain treatment procedures can be beneficial. Continuous treatmentmonitoring and multidisciplinary collaboration is an essential condition for effective control of cancer pain.
Keywords: cancer pain, opioids, adjuvant analgesics, cannabinoids, interventional pain treatment
Published: May 1, 2018 Show citation
References
- WHO. Cancer pain relief: report of a WHO expert committee. 2nd edition, WHO 1996.
- Kolektiv autorů. Metodické pokyny pro farmakoterapii bolesti. Bolest 2009; Suppl. 2.
- Rokyta R, Kršiak M, Kozák J. Bolest. Tigis, Praha 2012.
- Higginson IJ, Hearn J, Addington-Hall J. In: Sykes N,Fallon MT, Patt RB. Clinical Pain Management-Cancer Pain. London: Arnold 2003: 21-32.
- Watson CP. Moulin D, Watt-Watson J, et al. Conrolled-release oxycodone relieves neuropathic pain: a rendomised controlled trial in painful diabetic neuropaty. Pain 2003; 105: 71-78.
Go to original source... 
Go to PubMed... - Ahmedzai S, Brooks D. Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life. J Pain Symptom Manage 1997; 13: 254-261. Go to original source... Go to PubMed...
- Portenoy RK, et al. Oral transmucosal fentanyl (OTFC) for the treatment of breakthrough pain in cancer patiens. Pain 1999; 79: 303-312. Go to original source... Go to PubMed...